Symposium introduction: metabolic syndrome and the onset of cancer.
Diabetes, obesity, and related metabolic disorders are among the most pressing of today's health care concerns. Recent evidence from epidemiologic and basic research studies, as well as translational, clinical, and intervention studies, supports the emerging hypothesis that metabolic syndrome may be an important etiologic factor for the onset of cancer. On March 15-16, 2006, The Harvard Medical School Division of Nutrition hosted the symposium "Metabolic Syndrome and the Onset of Cancer" as a platform to systematically evaluate the evidence in support of this hypothesis. This symposium, which gathered leaders in the fields of metabolism, nutrition, and cancer, will stimulate further research investigating the etiologic role of metabolic syndrome in cancer. Furthermore, it will help to guide the development of effective cancer prevention strategies via nutritional and lifestyle modifications to alleviate metabolic syndrome.
Zhou
Jin-Rong
JR
Division of Nutrition, Harvard Medical School, Boston, MA, USA. jrzhou@bidmc.harvard.edu
Blackburn
George L
GL
Walker
W Allan
WA
D015897:Comorbidity; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications* / Q000453:epidemiology / Q000401:mortality; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000401:mortality; D012307:Risk Factors